![]() |
市場調查報告書
商品編碼
2046379
生物種子處理市場-全球產業規模、佔有率、趨勢、機會、預測:按類型、作物、處理方法、功能、地區和競爭格局分類,2021-2031年Biological Seed Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Crop, By Treatment Method, By Function, By Region & Competition, 2021-2031F |
||||||
全球生物種子處理市場預計將從 2025 年的 16.8 億美元大幅成長至 2031 年的 28.1 億美元,複合年成長率高達 8.95%。
這些處理劑是含有有益微生物、植物萃取物和發酵產物的天然農業材料,可直接施用於種子,用於病蟲害防治、疾病預防或提高植物活力。推動該市場發展的關鍵因素包括旨在減少對合成農藥依賴的嚴格法規,以及傳統農業系統中抗藥性管理的重要性。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 16.8億美元 |
| 市場規模:2031年 | 28.1億美元 |
| 複合年成長率:2026-2031年 | 8.95% |
| 成長最快的細分市場 | 微生物 |
| 最大的市場 | 北美洲 |
此外,全球向永續農業實踐的轉變正在推動這些解決方案的發展,因為它們對環境的影響很小,且與促進土壤健康的努力高度親和性。然而,生技藥品廣泛市場應用的主要障礙在於,其性能受環境條件影響較大,且儲存穩定性較差,尤其與合成替代品相比。儘管如此,該領域仍在快速發展。巴西作物生命協會(CropLife Brasil)的一份報告顯示,在2024/2025種植週期內,巴西生物投入品的使用率將成長13%,這凸顯了生物技術在主要農業經濟體中的快速整合。
對合成化學農藥的嚴格監管是全球生物種子處理市場的主要驅動力。世界各國政府正積極降低最大殘留限量(MRL),並逐步淘汰傳統活性成分的使用,迫使農民採用安全性更高、更符合監管要求的生物替代品。這種監管轉變正推動作物保護策略從以化學方法為主轉向以生物方法為主,尤其是在殘留限量嚴格的出口市場。因此,正如先正達集團2025年3月發布的報告所示,儘管整個作物保護產業面臨挑戰,但領先的農業公司在生物基產品領域仍實現了顯著成長。報告指出,儘管該公司整體作物保護銷售額下降了13%,但其生物來源生物來源產品業務在2024年全年保持了強勁成長。
此外,全球對有機和再生農業日益成長的興趣正在從根本上改變種子處理生技藥品的需求結構。這些農業實踐優先考慮土壤健康恢復,需要在播種時進行種子處理,將有益微生物引入根際,以改善養分吸收和土壤結構。這一趨勢正在推動工業界對支持這些農業系統的平台進行大幅投資。例如,2024年11月,拜耳將其再生農業計畫ForGround擴展到美國28州的種植戶,涵蓋12種經濟作物。這種永續轉型對市場的具體影響在近期區域銷售量的成長中得到了清晰的體現。科迪華農業科技公司報告稱,2024年第四季農作物保護產品的銷售量成長了16%,這主要得益於拉丁美洲對生技藥品和新技術的需求。
全球生物種子處理市場擴張的主要挑戰在於生物製藥的性能不穩定和儲存穩定性差。合成農藥能夠在各種田間條件下保持有效性並長期儲存,而生物材料通常由對溫度和濕度等環境因素高度敏感的微生物組成。如果這些處理劑在運輸過程中劣化或無法在土壤中正常定植,農民將面臨更大的經濟風險和難以預測的收成。這種固有的不穩定性導致農業生產者更傾向於選擇可靠性更高的化學產品,從而降低了生物解決方案的採用率。
與整個農業材料產業相比,這種被動式策略顯著限制了生物製品的市場滲透率。維持產品活性所需的複雜物流系統也削弱了經銷商的信心,並限制了分配給這些產品的貨架空間。例如,國際生物防治製造商協會估計,2024年,歐洲生物防治市場規模將達到16億歐元,約佔作物保護市場總額的10%。這些數據表明,儘管有監管支持,但與穩定性和可靠性相關的技術障礙阻礙了生技藥品與合成產品的有效競爭,並直接阻礙了整體市場成長。
用於種子處理防治線蟲的生物線蟲商業化進程正在推進,它們正迅速成為傳統土壤燻蒸劑的實用替代方案。與通常僅限於高價值園藝作物的傳統生物防治方法不同,現代生物線蟲製劑在各種農田中均展現出與合成標準相當的功效。這有效解決了線蟲抗性管理的關鍵挑戰,而近期應用率的提升正推動其在主要糧食作物中的廣泛應用。例如,2025年10月,Albaugh公司宣布其新型生物活性成分已應用於美國種子處理市場超過2,000萬英畝的農作物。
此外,大型農化集團對專業生技公司的策略性收購正在推動產業重組,並促成小眾技術的工業化規模應用。跨國公司透過將創新新創公司整合到其現有的全球供應鏈網路中,克服了以往在分銷物流和配方一致性方面面臨的挑戰。這確保了這些精密的生物技術材料能夠在保持其有效性的同時,觸及更廣泛的市場。這種整合方式與整合後的生技產品系列的銷售量顯著成長直接相關。例如,Corteva AgriScience 於 2025 年 11 月發布的一份報告強調,其生技和新產品領域的銷售量實現了兩位數的成長,證實了所收購的生技資產已成功實現商業性化。
The Global Biological Seed Treatment Market is projected to expand significantly, from USD 1.68 Billion in 2025 to USD 2.81 Billion by 2031, exhibiting an impressive compound annual growth rate of 8.95%. These treatments are natural agricultural inputs, including beneficial microorganisms, plant extracts, and fermentation byproducts, applied directly to seeds to control pests and diseases or boost plant vitality. Key factors propelling this market include strict regulations aimed at reducing dependence on synthetic agrochemicals and the crucial requirement for resistance management in traditional farming systems.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.68 Billion |
| Market Size 2031 | USD 2.81 Billion |
| CAGR 2026-2031 | 8.95% |
| Fastest Growing Segment | Microbials |
| Largest Market | North America |
Moreover, the global push for sustainable agricultural methods champions these solutions due to their lower environmental impact and enhanced compatibility with initiatives promoting soil health. However, a major hurdle to wider market adoption is the variable performance and poor shelf stability of biological formulations in different environmental conditions, especially when compared to synthetic alternatives. Nonetheless, the sector demonstrates rapid progress, with bioinput adoption in Brazil increasing by 13% during the 2024/2025 crop cycle, as reported by CropLife Brasil, underscoring the swift integration of biological technologies into leading agricultural economies.
Market Driver
Strict regulations on synthetic chemical pesticides are a key driver for the Global Biological Seed Treatment Market. Governments globally are actively reducing Maximum Residue Limits (MRLs) and discontinuing traditional active ingredients, thereby obliging farmers to adopt biological alternatives that offer superior safety profiles and compliance. This regulatory push is shifting crop protection strategies from primarily chemical to more biologically inclusive methods, especially in export markets with stringent residue standards. As a result, major agricultural businesses are experiencing notable growth in their biological offerings, even as the broader crop protection sector faces challenges, as evidenced by Syngenta Group's March 2025 report, which showed robust growth in its biologicals business throughout 2024, despite a 13% sales decline in its overall crop protection segment.
Furthermore, the rising global embrace of organic and regenerative farming is fundamentally altering the demand landscape for seed-applied biologicals. These agricultural approaches prioritize restoring soil health, requiring seed treatments that introduce beneficial microbes into the rhizosphere at planting to improve nutrient uptake and soil structure. This trend is attracting substantial industrial investment into platforms supporting such agronomic systems; for instance, Bayer expanded its ForGround regenerative agriculture program in November 2024 to growers across 28 U.S. states, covering 12 different cash crops. The concrete market effect of these sustainable transitions is clear in recent regional volume increases, with Corteva Agriscience reporting a 16% rise in Crop Protection volumes in Q4 2024, largely driven by demand for biologicals and new technologies in Latin America.
Market Challenge
A primary challenge limiting the expansion of the Global Biological Seed Treatment Market is the inconsistent performance and poor shelf stability of biological formulations. Unlike synthetic agrochemicals, which maintain their effectiveness and can be stored for extended periods across various field conditions, biological inputs often comprise living organisms highly susceptible to environmental factors like temperature swings and humidity. When these treatments deteriorate during distribution or fail to properly establish in the soil, farmers encounter heightened financial risks and unpredictable harvest results. This inherent variability leads agricultural producers to favor the reliability of chemical options, thereby curbing the adoption rate of biological solutions over conventional inputs.
This reluctance significantly constrains the market penetration of biological products compared to the broader agricultural inputs industry. The intricate logistics necessary to preserve product viability also erode distributor confidence and limit available shelf space for these treatments. Illustrating this gap, the European biocontrol market was valued at 1.6 billion Euros in 2024, making up approximately 10% of the entire crop protection market, according to the International Biocontrol Manufacturers Association. This data indicates that even with regulatory encouragement, technical hurdles related to stability and dependability hinder biologicals from effectively competing with synthetic products, directly impeding overall market growth.
Market Trends
The growing commercialization of bio-nematicides for seed-applied nematode control is quickly emerging as a practical substitute for traditional soil fumigants. In contrast to earlier biological solutions, which were frequently confined to high-value horticultural crops, contemporary bio-nematicide formulations now offer efficacy comparable to synthetic benchmarks in broad-acre farming. This effectively tackles the vital challenge of nematode resistance management, with the shift towards widespread adoption in key staple crops supported by recent deployment figures. For example, Albaugh announced in October 2025 that its new biological active ingredient has been successfully applied across over 20 million acres of row crops in the U.S. seed treatment market.
Furthermore, strategic acquisitions of specialized biological companies by leading agrochemical conglomerates are driving sector consolidation and enabling the industrial scaling of niche technologies. By incorporating innovative startups into their existing global supply networks, multinational corporations are surmounting past hurdles concerning distribution logistics and formulation consistency. This ensures that these sensitive biological inputs reach a broader market while preserving their viability. This consolidation approach is directly resulting in significant volume expansion for integrated biological portfolios, as evidenced by Corteva Agriscience's November 2025 report, which highlighted double-digit volume growth in its biologicals and new product segments, confirming the successful commercial scaling of its acquired biological assets.
Report Scope
In this report, the Global Biological Seed Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Biological Seed Treatment Market.
Global Biological Seed Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: